Library

άλφα-D2PV

α-D2PV replaces the α-PVP propyl tail with a phenyl ring, lowering potency versus α-PVP but remaining far stronger than MDMA. It first appeared in forensic seizures in late 2020 and is often mis-sold as MDMA, leading to 100 mg-scale overdoses. Harm-reduction groups list 20-50 mg as the entire active range; stay below 35 mg until identity is confirmed. Users describe rapid onset rush, intense peripheral vasoconstriction (cold extremities, chest pressure), and a short 2-hour plateau followed by edgy stimulation that tempts redosing.

Also known as: Dppe

Classification

  • Chemical: Cathinone
  • Psychoactive: Psychedelic
  • Psychoactive: Stimulant
  • Tag: Atypical Hallucinogen
  • Tag: Pyrrolidine
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Teeth Grinding
  • Vasoconstriction
  • Insomnia
  • Jaw Tension
  • Coldness
  • Euphoria
  • Talkativeness
  • Hyperfocus
  • Compulsive Redosing
  • Anxiety
  • Paranoia
  • Increased Libido
  • Light Sensitivity
  • Open Eye Visuals
  • Auditory Distortion
  • Tactile Enhancement
  • Geometric Imagery

Routes of Administration

Oral

Dosage

  • Threshold: 5 mg
  • Light: 10-20 mg
  • Common: 20-35 mg
  • Strong: 35-50 mg
  • Heavy: 50 mg+

Duration

  • Onset: 0.25-0.5 h
  • Peak: 0.5-1.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-8 h
  • Total Duration: 1.5-3 h

Sublingual

Dosage

  • Threshold: 5 mg
  • Light: 10-20 mg
  • Common: 20-35 mg
  • Strong: 35-50 mg
  • Heavy: 50 mg

Duration

  • Onset: 0.17-0.33 h
  • Peak: 0.5-1.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-8 h

Insufflated

Dosage

  • Threshold: 3 mg
  • Light: 5-15 mg
  • Common: 15-30 mg
  • Strong: 30-45 mg
  • Heavy: 45 mg+

Duration

  • Onset: 0.08-0.25 h
  • Peak: 0.5-1.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-8 h
  • Total Duration: 1.5-2.5 h

Vaporized / Smoked

Dosage

  • Threshold: 2 mg
  • Light: 5-10 mg
  • Common: 10-25 mg
  • Strong: 25-35 mg
  • Heavy: 35 mg

Duration

  • Onset: 0.08-0.25 h
  • Peak: 0.5-1.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-8 h

Intravenous

Dosage

  • Threshold: 1 mg
  • Light: 2-5 mg
  • Common: 5-10 mg
  • Strong: 10-20 mg
  • Heavy: 20 mg+

Duration

  • Onset: 0-0.02 h
  • Peak: 0.03-0.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-8 h
  • Total Duration: 0.8-1.5 h

Vaporized

Dosage

  • Heavy: 35 mg+
  • Light: 5–10 mg
  • Common: 10–25 mg
  • Strong: 25–35 mg
  • Threshold: 2 mg

Duration

  • Onset: 0.03-0.17 h
  • Peak: 0.25-0.75 h
  • Offset: 0.75-1.5 h
  • After Effects: 1.5-6 h
  • Total Duration: 1-2 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

alpha-D2PV - Οδηγός ουσίας DrugsPRO

alpha-D2PV: α-D2PV replaces the α-PVP propyl tail with a phenyl ring, lowering potency versus α-PVP but remaining far stronger than MDMA. It first appeared in forensic seizures in late 2020 and is often mis-sold as MDMA, leading to 100 mg-scale overdoses. Harm-reduction groups list 20-50 mg as the e

Related pages